Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
* Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A growing number of top
3 May 13 10:03LONDON, May 2 (Reuters) - JP Morgan and Greenhill have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds ($1.6 billion). A spokesman for Britain's biggest drugmaker said on Thursd
2 May 13 08:58GlaxoSmithKline has been hit by a delay to one of the six key drugs on which it was awaiting regulatory decisions this year. The US Food and Drug Administration (FDA) moved the date when it will votes on whether to approve or reject GSK's experimental cancer drug Trametinib back to September 3rd 2
1 May 13 12:42* EU court stops EMA releasing AbbVie, InterMune drug data * Medicines agency says will appeal interim ruling * EMA head says public distrust makes transparency vital By Ben Hirschler LONDON, April 30 (Reuters) - The head of Europe's medicines regulator is digging in for a
30 Apr 13 19:04LAGOS, April 30 (Reuters) - The Nigerian unit of British drugmaker GlaxoSmithKline said on Tuesday its 2012 pretax profit rose 20 percent to 4.17 billion Nigerian naira ($26.41 million), from 3.49 billion naira the previous year. Turnover grew to 25.31 billion naira during the period, comp
30 Apr 13 13:34April 29 (Reuters) - Impax Laboratories Inc said partner GlaxoSmithKline Plc ended their collaboration on Impax's experimental Parkinson's disease drug due to regulatory and launch delays in the countries in which GSK has rights to market the drug. Impax shares fell 2 percent to $17.32 in p
29 Apr 13 12:46April 26 (Reuters) - The U.S. Food and Drug Administration said the an anti-seizure drug developed by Valeant Pharmaceuticals Inc and co-marketed with GlaxoSmithKline Plc may cause eye and skin problems. The U.S. health regulator warned that the drug, Potiga, may cause bluish skin predomina
26 Apr 13 22:22April 26 (Reuters) - The U.S. Food and Drug Administration said the an anti-seizure drug developed by Valeant Pharmaceuticals Inc and co-marketed with GlaxoSmithKline Plc may cause eye and skin problems. The U.S. health regulator warned that the drug, Potiga, may cause bluish skin predomina
26 Apr 13 21:35(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks on the move on Friday: WALL STREET LOWER AFTER G
26 Apr 13 18:22(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks on the move on Friday: WALL STREET DIPS AFTER DA
26 Apr 13 15:18(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks to watch on Friday: WALL ST OPENS LOWER AFTER GD
26 Apr 13 13:53(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks to watch on Friday: FUTURES EXTEND DECLINES AFTE
26 Apr 13 13:18(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks to watch on Friday: FUTURES EXTEND DECLINES AFTE
26 Apr 13 13:06(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s, for the Morning News Call newsletter, http://link.reuters.com/faq23t) April 26 (Reuters) - Some U.S. stocks to watch on Friday: FUTURES LOWER WITH GDP DATA,
26 Apr 13 12:16(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s) April 26 (Reuters) - Some U.S. stocks to watch on Friday: STOCK INDEX FUTURES FALL, FOCUS ON GDP DATA Index futures pointed to a lower open on Wall Str
26 Apr 13 11:30
Last checked at